header

BioProcess International Conference & Exhibition
Managing Manufacturing Networks Product Lifecycle Management
Cell Culture & Upstream Processing Recovery & Purification
September 20-24, 2010 * Providence, Rhode Island, USA New Programming for Vaccines, Raw Material & Suppliers, Emerging Analytical Requirements

navigation

Registration

Online Registration is Open!

Sponsors

  • Platinum Sponsors

    BD Biosciences - Advanced Bioprocessing

  • Xcellerex, Inc

Founding Publication

BioProcess International

Learn more about receiving a free subscription.

Find Another IBC Event

Event Search Form by Industry

LinkedIn

toolbar

Alternate Language Options:
  • Korean
  • Chinese
  • Taiwanese
  • English
  • Recommend to a Friend
  • LinkedIn
  • News Feeds
  • Blog

Event Information

Conference: September 20 - 24, 2010 · Exhibition: September 21-23, 2010 · Rhode Island Convention Center · Providence, RI

Document Title

Scientific Advisory Committees

Scientific Advisory Committees

Managing Manufacturing Networks

  • Chris Antoniou, Principal Engineer, Global Engineering and Technology, Biogen Idec
  • Barak I. Barnoon, Director, Biotech Process Engineering, Pfizer Global Engineering, Pfizer Inc.
  • Peter Latham, President, BioPharm Services US
  • Duncan Low, Ph.D., Scientific Executive Director, Process Development, Amgen, Inc.
  • Wolfgang Noe, Ph.D., Vice President, Bioprocess Development, Biogen Idec
  • Curran Simpson, Senior Vice President, Operations, Human Genome Sciences, Inc.
  • Victor A. Vinci, Ph.D., Director, Bioprocess Operations, Lilly Research Labs, Eli Lilly and Company

Process Development throughout the Product Lifecycle

  • Shishir Gadam, Ph.D., Director, Manufacturing Science and Technology, Genentech Inc.
  • Roger A. Hart, Ph.D., Scientific Director, Process & Product Engineering, Amgen
  • Maninder Hora, Ph.D., Vice President, Product Operations, Facet Biotech
  • Dr. Guenter Jagschies, Senior Director, Strategic Customer Relations, GE Healthcare Life Sciences, Sweden
  • Howard L. Levine, Ph.D., President, BioProcess Technology Consultants, Inc.
  • Ellen L. McCormick, Director, Primary Care and Oncology Portfolio, BioSciences Group, Pfizer Global Manufacturing, Pfizer, Inc
  • Abhinav Shukla, Ph.D., Associate Director Manufacturing Sciences, Bristol-Myers Squibb

Recovery & Purification

  • Amit Banerjee, Ph.D., Research Fellow, Global Biologics, Worldwide Pharmaceutical Sciences, Pfizer Inc.
  • Chris Dowd, Ph.D., Senior Engineer, Late Stage Purification, Genentech, Inc.
  • Sanchayita Ghose, Ph.D., Manager, Process Sciences Downstream, Bristol-Myers Squibb
  • Ranga Godavarti, Drug Substance Development, Wyeth BioPharma (invited)
  • Uwe Gottschalk, Ph.D., Vice President, Purification Technology, Sartorius Stedim Biotech, Germany
  • David W. Kahn, Ph.D., Director, Late-Stage Purification Development, Human Genome Sciences, Inc.
  • Natraj Ram, Ph.D., Senior Group Leader, Purification, Technical Operations, Abbott Bioresearch Center
  • Tim Tressel, Ph.D., Director, Purification Process Development, Amgen, Inc.
  • Peter W. Wojciechowski, Ph.D., Director, Process Development, Advanced Technologies and Regenerative Medicine, LLC (ATRM)

Cell Culture and Upstream Processing

  • Susan Casnocha, Ph.D., Research Fellow, Bioprocess R&D, Culture Process Development, BioTherapeutics Pharmaceutical Sciences, Pfizer
  • Martin Gawlitzek, Ph.D., Senior Scientist & Senior Group Leader, Late Stage Cell Culture, Process R&D, Genentech, Inc.
  • Chetan T. Goudar, Ph.D., P.E., Head, Cell Culture Development, Global Biological Development, Bayer HealthCare
  • Kevin Kayser, Ph.D., R&D Manager, Cell Culture Engineering, SAFC Biosciences
  • Denny Kraichely, Ph.D., Associate Director, CMC Team Lead, Portfolio Management & Technical Integration, Johnson & Johnson Pharmaceutical R&D, Inc.
  • Charles Sardonini, Ph.D., Associate Director, Process Engineering/Development, Genzyme Corp.
  • Torsten W. Schulz, Ph.D., Associate Director, Biopharmaceutical Process Science, Boehringer Ingelheim Pharma GmbH & Co. KG, Germany
  • Thomas Seewoester, Ph.D., Director, Process Development, Amgen Inc.
  • Andrew Snowden, Ph.D., Senior Scientist, Cell Culture Development, Biogen Idec
  • Gary J. Welch, Director, Process Science, Abbott Bioresearch Center
  • Kelly Wiltberger, Senior Manager, Biopharm Development, Biogen Idec
courses banner
Preclinical Scale Bioprocessing banner

footer